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Tumor cell adaptation to hypoxic stress is an important
determinant of malignant progression. While much em-
phasis has been placed on the role of HIF-1 in this context,
the role of additional mechanisms has not been adequately
explored. Here we demonstrate that cells cultured under
hypoxic/anoxic conditions and transformed cells in
hypoxic areas of tumors activate a translational control
program known as the integrated stress response (ISR),
which adapts cells to endoplasmic reticulum (ER) stress.
Inactivation of ISR signaling by mutations in the ER
kinase PERK and the translation initiation factor eIF2a
or by a dominant-negative PERK impairs cell survival
under extreme hypoxia. Tumors derived from these
mutant cell lines are smaller and exhibit higher levels
of apoptosis in hypoxic areas compared to tumors with an
intact ISR. Moreover, expression of the ISR targets ATF4
and CHOP was noted in hypoxic areas of human tumor
biopsy samples. Collectively, these findings demonstrate
that activation of the ISR is required for tumor cell adapta-
tion to hypoxia, and suggest that this pathway is an
attractive target for antitumor modalities.
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Introduction
The development of fluctuating hypoxic and anoxic regions
in tumors has profound consequences for malignant progres-
sion, response to therapy and overall patient survival (Hockel
and Vaupel, 2001). Elucidating the processes that enable
tumor cells to adapt to the unfavorable conditions of hypoxia
is critical for understanding malignant progression and for
developing more effective antitumor modalities. The hypoxia-
inducible factor 1 (HIF-1) plays a key role in tumor cell
adaptation to hypoxia by regulating the expression of over
60 genes involved in angiogenesis, anaerobic glycolysis and
cell survival (Ratcliffe et al, 1998; Semenza, 2000). Loss-of-
function studies indicate that, in most cases, HIF-1 promotes
overall tumor growth (Maxwell et al, 1997; Ryan et al, 2000).
However, the role of HIF-1 is complex and may be dependent
on the tumor microenvironment (Carmeliet et al, 1998;
Blouw et al, 2003).
The hypoxic cell also elicits additional, HIF-1-independent
adaptive responses that contribute to increased survival
under low oxygen conditions. An immediate reaction to
hypoxia is a reduction in the rates of global protein synthesis
that is thought to reduce energy demands when oxygen and
ATP levels are low (Hochachka et al, 1996). This translational
inhibition appears to occur in distinct phases and to involve
multiple pathways. We have previously shown that hypoxia
rapidly increases phosphorylation of the translation initiation
factor eIF2a through activation of the endoplasmic reticulum
(ER) kinase PERK (Koumenis et al, 2002; Blais et al, 2004).
These events serve two major functions in a cell experiencing
ER stress. The first is to rapidly downregulate protein synth-
esis, which reduces the ER protein load and leads to lower
energy expenditure, since both protein synthesis and protein
folding are ATP-requiring processes (Dorner et al, 1990; Shi
et al, 1998; Harding et al, 2000b). The second is to upregulate
genes that promote amino-acid sufficiency and redox homeo-
stasis (Harding et al, 2003), thereby further promoting cell
survival. Some, but not all of the effects of PERK are mediated
by the transcription factor ATF4, which is translationally
upregulated by ER stress in an eIF2a phosphorylation-depen-
dent manner (Harding et al, 2000a, 2003). This pathway,
known as the integrated stress response (ISR) (Ron, 2002),
constitutes one arm of a larger coordinated program called
the unfolded protein response (UPR), which facilitates the
cell to adapt to ER stress. Cells with compromised PERK
and eIF2a signaling are substantially more sensitive to
ER-induced cell death than wild-type cells (Harding et al,
2000b, 2001; Scheuner et al, 2001; Zhang et al, 2002).
Recently, it was reported that hypoxia upregulates ATF4 in
a PERK-dependent manner (Blais et al, 2004) and that ATF4
levels are increased by anoxic stress and in human tumors
(Ameri et al, 2004). These findings prompted us to investigate
the physiological role for the ISR in cellular adaptation to
hypoxia in vitro and in tumor development in vivo. We report
that hypoxia/anoxia activates the ISR pathway in vitro and
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in vivo, and that several proteins previously implicated in the
UPR are also upregulated by hypoxia. Expression of ATF4
and CHOP colocalizes with hypoxic areas of primary human
tumors and animal xenografts, and inactivation of the ISR
compromises cell survival during hypoxia in vitro and in vivo
and significantly impairs tumor growth. These findings estab-
lish the ISR as an important mediator of hypoxia tolerance
and tumor growth, and raise the possibility that the ISR may
be an attractive target for antitumor modalities.
Results
Hypoxic/anoxic stress induces expression of ISR genes
in a PERK- and eIF2a-phosphorylation-dependent
manner
To investigate the effects of hypoxia on the expression of ISR-
related genes, mouse embryonic fibroblasts (MEFs) from
PERKþ /þ and PERK/ animals were exposed to extreme
hypoxia (p0.02%) or were treated with thapsigargin, an
inhibitor of the SERCA (Ca2þ -ATPase) pump and potent
ER stressor (Note: for brevity, hypoxia in the text denotes
extreme hypoxia unless otherwise noted). Consistent with
previous findings (Koumenis et al, 2002), hypoxia and thap-
sigargin caused a time-dependent increase in PERK autophos-
phorylation and eIF2a phosphorylation in PERKþ /þ MEFs
(results not shown). Phosphorylation of eIF2a stimulates
translational upregulation of ATF4, which activates the ex-
pression of downstream targets involved in the UPR, such
as CHOP. As shown in Figure 1A, ATF4 levels increased by
hypoxia and thapsigargin in the PERKþ /þ MEFs, whereas
this increase was transient and considerably attenuated in
PERK/ MEFs. Induction of CHOP did not occur until after
16 h of hypoxia, reflecting a requirement for ATF4 accumula-
tion. BiP was not significantly increased by hypoxia.
Hypoxia-induced ATF4 accumulation occurred primarily
at the post-transcriptional level, because ATF4 mRNA levels
were not upregulated in hypoxic PERKþ /þ MEFs
(Figure 1B). CHOP and BiP mRNA levels were substantially
increased by hypoxia and by thapsigargin in PERKþ /þ and
PERK/ MEFs. The increase in CHOP was higher after 16 h
of hypoxia in the PERKþ /þ cells, consistent with the higher
levels of ATF4 protein in these cells, but PERK status had no
effect on the increase in BiP mRNA levels.
Although hypoxia induced a largely PERK-independent
increase in CHOP mRNA, there was a strong PERK depen-
dence on CHOP protein accumulation, suggesting that the
translational efficiency of CHOP mRNA might be regulated in
a PERK-dependent manner. Thus, we analyzed the levels of
both overall and gene-specific translation in the PERKþ /þ
and PERK/ cell lines. We have previously shown that
inhibition of global translation during hypoxia is dependent
on PERK at early times after hypoxia (o8 h), but, after longer
Figure 1 Extreme hypoxia induces ATF4 and CHOP upregulation in a PERK-dependent manner. PERKþ /þ and PERK/ MEFs were exposed
to p0.02% O2 or treated with 1 mM thapsigargin for the times indicated. (A) Immunoblots with anti-ATF4, anti-CHOP, anti-BiP and anti-b-actin
(loading control). Different time points are used since induction of ATF4 occurs much earlier than CHOP or BiP. (B) Northern blot analysis of
UPR mRNAs following hypoxia and thapsigargin treatments. PERKþ /þ and PERK/ MEFs were treated as in (A). Blotting for a-tubulin was
used as a loading control. (C) Translation efficiency of CHOP mRNA following hypoxia. PERKþ /þ and PERK/ MEFs were treated as in (A)
and lysates were subjected to sucrose gradient sedimentation. Polysome profiles shown are from cell lysates of aerobic and hypoxic PERKþ /þ
cells. The positions of the 40S and 60S subunits as well as the polysomal RNA are indicated. (D) The amounts of CHOP, b-actin and 18S mRNA
were determined by real-time quantitative PCR in each of the polysome fractions. The gray column indicates the polysome fraction used for
quantitative PCR. Values plotted represent the total amount of CHOP mRNA found within the polysomes relative to b-actin. Also shown is the
total cellular amount of CHOP found in the PERKþ /þ and PERK/ MEFs normalized to b-actin as determined by quantitative RT–PCR.
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periods of hypoxia translation, is inhibited in both PERKþ /þ
and PERK/ cells (Koumenis et al, 2002). As shown in
Figure 1C, 16 h of hypoxia caused a strong inhibition of
translation initiation in the PERKþ /þ cells, as evident by a
reduction in polysomal RNA and an increase in free mono-
some and ribosome subunits. A similar inhibition was
observed in PERK/ cells after 16 h of hypoxia; however,
following 2 h hypoxia, translation was inhibited much more
strongly in the PERKþ /þ compared to PERK/ cells (data
not shown). To explore potential PERK-dependent differences
in specific CHOP mRNA translation following prolonged
hypoxia, polysome fractions were collected and individually
analyzed by quantitative RT–PCR for the levels of 18S, actin
and CHOP. In both PERKþ /þ and PERK/ cells, the levels of
actin associated with polysomes decreased during hypoxia in
accordance with the drop in overall translation. In contrast,
CHOP mRNA levels increased substantially within the poly-
somes. Notably, the relative increase in CHOP mRNA within
the polysomes was approximately four times higher in the
PERKþ /þ cells than in the PERK/ cells (Figure 1D). Thus,
in addition to an increase in CHOP mRNA, there is a
significant PERK dependence on polysome association of
CHOP mRNA during hypoxia.
Similarly, by coupling ribosome fractionation with micro-
array gene analysis, we identified changes in steady-state
gene expression and translation-mediated changes in HeLa
cells following 16 h of extreme hypoxia. We found that the
mRNA levels of genes associated with the UPR (including
ORP150, heme oxygenase; HO-1 and MIF1) were not only
substantially induced by hypoxia but also remained effi-
ciently translated, as indicated by their association with
high-molecular-weight polysomes (Figure S1). Conversely,
the free total and polysome-bound mRNA levels of genes
associated with other types of stress, such as the heat-shock
response (HSF2, HSP70) or of constitutively synthesized
genes (ribosomal protein S20 and HSC70), were either only
weakly upregulated or substantially downregulated by hypoxia.
Prolonged hypoxia induces apoptosis
in a PERK-dependent manner
Cells with a compromised UPR are more susceptible to ER
stress-induced apoptosis compared to cells with an intact
UPR (Kaufman, 2002; Ma and Hendershot, 2004). We pre-
viously reported that PERK/ cells exhibit reduced clono-
genic survival under extreme hypoxia compared to PERKþ /þ
cells (Koumenis et al, 2002). To determine whether the
difference in clonogenic survival was due to differential
apoptotic sensitivity, we assayed for cleavage of caspase-12,
caspase-3 and PARP following exposure to extreme hypoxia.
Caspase-12, associated with the ER, is cleaved during ER
stress and this event can be used as an indicator of UPR
activation (Nakagawa et al, 2000; Rao et al, 2001). Exposure
of PERK/ cells to hypoxia resulted in higher levels of
caspase-12 cleavage (as evident by the disappearance of the
procaspase-12 form) by 9 h of hypoxia compared to PERKþ /þ
cells (Figure 2A). However, caspase-12/ MEFs were as
sensitive as caspase-12þ /þ MEFs under hypoxia (results
not shown), indicating that, while caspase-12 processing is
a marker of hypoxia-induced ER stress, it cannot account for
the higher sensitivity of PERK/ cells to hypoxia. Activation
of caspase-3, a terminal caspase and proteolytic processing
of PARP, a marker for late-stage apoptosis, followed a similar
pattern with higher levels of cleaved caspase-3 and PARP
in the PERK/ compared to PERKþ /þ cells (Figure 2B and C)
following treatments with hypoxia and thapsigargin. These
results indicate that PERK contributes to cellular survival
under prolonged hypoxia.
PERK contributes to tumor growth in vivo
The increased sensitivity of PERK/ cells to hypoxic stress
in vitro suggested that PERK might play a role in tumor
growth in vivo. To investigate this possibility, PERKþ /þ
and PERK/ MEFs were immortalized with SV40 large/
small T-antigen and transformed with oncogenic Ki-RasV12.
This transformation did not cause any overt morphological
differences between the two cell lines (data not shown).
Phosphorylation of ERK1 and ERK2 was analyzed in
PERKþ /þ and PERK/ MEFs with or without Ki-RasV12.
As expected, expression of Ki-RasV12 increased ERK phos-
phorylation without affecting the levels of total ERK1 and
ERK2. The extent of this phosphorylation was comparable
in PERKþ /þ and PERK/ MEFs (Figure 3A), suggesting that
PERK does not influence Ki-RasV12 signaling. Further experi-
ments demonstrated that PERK status did not affect the
in vitro growth kinetics or the ability of the Ki-RasV12-
transformed cell lines to grow colonies in soft agar (Figures
3B and C).
Equal numbers of these transformed MEFs were injected in
the flanks of nude mice and tumor growth was monitored
over a period of 3–4 weeks. Tumors from PERKþ /þ .RasV12
MEFs grew faster and larger compared to those from the
PERK/.RasV12 MEFs (Figures 3D and E). Several PERK/
tumors displayed an opaque morphology with apparent
necrosis of the skin when the experiment was terminated
(Figure 3D, top). Analysis of eIF2a phosphorylation status in
homogenized tissue revealed markedly higher levels of phos-
phorylated eIF2a in PERKþ /þ tumors compared to PERK/
Figure 2 PERK confers resistance to hypoxia-induced apoptosis.
(A–C) PERKþ /þ and PERK/ MEFs were exposed to p0.02% O2
or treated with 500 nM thapsigargin for the indicated times before
immunoblotting with antibodies specific for procaspase-12 (A),
cleaved caspase-3 or anti-b-actin (B), or cleaved and uncleaved
PARP (C).
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tumors, indicating PERK-dependent eIF2a phosphorylation
caused by the tumor microenvironment (Figure 3D, bottom).
On average, PERKþ /þ tumors grew approximately six times
larger than PERK/ tumors after 22 days (average
26477573 versus 3917101 mm3, N¼ 7) (Figure 3E). Similar
results were obtained when Ha-RasV12 instead of Ki-RasV12
was used to transform PERKþ /þ and PERK/ MEFs (data
not shown).
To minimize the effect of random clonal variation in this
experimental system, we also examined the in vivo growth of
individual clones of Ki-RasV12-transfected cells. Although
the growth kinetics of PERKþ /þ .Ki-RasV12.#2 and PERK/.
Ki-RasV12.#2 MEFs were indistinguishable in vitro (results
not shown), the PERK/ tumors failed to grow beyond a few
mm in size (Figures 3F and G). Collectively, these results
indicate that PERK status affects tumor growth in a manner
that is independent of in vitro growth characteristics, suggest-
ing that the differential response of these cells to the
tumor microenvironment must play a critical role in tumor
development.
PERK confers resistance to hypoxia-induced apoptosis
in vivo
The compromised ability of PERK/ cells to tolerate hypoxic
conditions in vitro and the slower growth of PERK/ tumors
suggested that the presence of PERK increased the ability of
Figure 3 PERK affects the rate of tumor growth in vivo. (A) Immunoblot of untransformed PERKþ /þ and PERK/ MEFs, and MEFs stably
transformed with Ki-RasV12, using a phospho-specific anti-ERK1/2 antibody (top), or an antibody against total ERK1 and ERK2 (bottom).
(B) Growth rates of Ki-RasV12-transformed PERKþ /þ and PERK/ MEFs in vitro. (C) PERKþ /þ .Ki-RasV12 and PERK/.Ki-RasV12 MEFs form
colonies in soft agar at similar rates. (D) Top, picture of a representative nude mouse injected with PERKþ /þ .Ki-RasV12 MEFs (left flank) and
PERK/.Ki-RasV12 MEFs (right flank) with 3106 cells/site at 22 days following injection. The bottom panel shows eIF2a phosphorylation
levels from the excised tumors shown in the top panel. Tumor sections were homogenized and immunoblotted for phospho-eIF2a and total-
eIF2a. (E) PERKþ /þ (blue line and squares) and PERK/ (green line and triangles) tumor volumes from seven animals monitored over
a period of 22 days following inoculation (mean7s.e.). (F) Tumors from a mouse injected with clone #2 PERKþ /þ .Ki-RasV12 MEFs (left) or
clone #2 PERK/.Ki-RasV12 MEFs (right). (G) Growth of PERKþ /þ .Ki-RasV12#2 (blue line and rectangles) and PERK/.Ki-RasV12#2 (green
line and triangles) tumors (N¼ 4) monitored over a period of 37 days (mean7s.e.).
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transformed MEFs to survive tumor hypoxia, resulting in
tumors with larger hypoxic areas. We therefore studied the
patterns of cell death in relation to areas of hypoxia within
PERKþ /þ and PERK/ tumor sections. The hypoxia marker
EF-5 is metabolized and forms macromolecular adducts
preferentially in hypoxic areas that can be visualized using
a Cy3-labeled anti-EF5 adduct antibody. Nude mice with
PERKþ /þ .Ki-RasV12 and PERK/.Ki-RasV12 flank tumors
were injected with EF-5 and sections were co-stained with
Cy3-labeled anti-EF5 antibody and with an anti-cleaved cas-
pase-3 antibody. The patterns of EF-5 and caspase-3 staining
in the PERKþ /þ and PERK/ tumors were quite distinct. In
PERK/ tumors, areas of hypoxia were fewer and smaller
compared to the PERKþ /þ tumors (Figure 4A). Image ana-
lysis revealed that B70% of apoptotic cells in four distinct
fields colocalized with hypoxic areas (Figure 4B). In contrast,
PERKþ /þ tumors exhibited more extensive areas of hypoxia
that were largely devoid of apoptotic cells, with only B22%
apoptotic cells being within the hypoxic areas. Strong stain-
ing for cleaved caspase-3 was observed only in areas sur-
rounded by a ‘hypoxic ring’, which is indicative of a necrotic
tumor area. Similar results were obtained from two indepen-
dent tumors of each cell line. These results suggest that
PERKþ /þ .Ki-RasV12 MEFs can better tolerate hypoxia
in vivo, resulting in larger tumors with extensive hypoxic
areas. In contrast, PERK/.Ki-RasV12 MEFs, which are more
sensitive to hypoxia, form smaller tumors with fewer hypoxic
areas. Since hypoxic areas in vivo are usually accompanied by
conditions of low pH and/or growth factor levels, it is
possible that the sensitivity of the PERK/ cells in vivo
may be due not only to low oxygen levels but also to these
factors as well.
Cells with a nonphosphorylatable ‘knock-in’ mutation
of eIF2a display attenuated induction of ISR genes
under hypoxia, and are sensitive to hypoxic stress
Although eIF2a phosphorylation is a primary target of acti-
vated PERK, it has been suggested that PERK phosphoryla-
tion may activate additional targets (Cullinan et al, 2003). To
further study the role of the ISR in tumor cell adaptation to
hypoxic stress, we used MEFs in which the endogenous eIF2a
gene has been genetically replaced by a nonphosphorylatable
(S51A) allele. These cells display dramatically reduced down-
stream effector responses to ER stress and other stresses
that induce eIF2a phosphorylation (Scheuner et al, 2001).
Exposure of these cells to hypoxia failed to induce eIF2a
Figure 4 Hypoxic areas in PERK/ but not in PERKþ /þ tumors overlap with areas of apoptosis. (A) Sections of PERK/ tumors (af) or
PERKþ /þ tumors (gl) were incubated with a Cy3-conjugated antibody to EF-5 adducts (hypoxia, red) (b, e and h, k), followed by incubation
with a FITC-conjugated anti-cleaved caspase-3 antibody (apoptosis, green) (a, d and g, j). Panels c, f and i, l are merged images showing both
apoptotic and hypoxia areas. Two different PERK/ (ac and df) and PERKþ /þ (gi and jl) tumor sections are shown. Bar¼ 15 mm (ai)
and 60mm (jl). (B) Quantitation of four independent field images from PERKþ /þ or PERK/ tumors. The number of apoptotic cells in
hypoxic (EF-5 positive) and normoxic (EF-5 negative) areas of each image were automatically counted and expressed as a percentage of the
total number of apoptotic cells in the image. Error bars represent s.e. values.
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phosphorylation (Figure 5A) and induction of ISR proteins
ATF4 and CHOP by hypoxia was significantly attenuated
(Figure S2A). At the mRNA level, hypoxia again failed to
induce a significant upregulation of ATF4 (Figure S2B),
further confirming that the induction of ATF4 by hypoxia is
post-transcriptional (Blais et al, 2004).
The S51A knock-in mice display striking phenotypic simi-
larities with the PERK knockout mice, particularly in the
sensitivity of cells with specialized and increased secretory
capacity to endogenous ER stress (Harding et al, 2001;
Scheuner et al, 2001). To determine whether similar parallels
exist in the response of PERK/ and S51A cells to hypoxic
stress, we transformed S51A and wild-type MEFs (WT-MEFs)
with SV40 large/small T-antigen and mutant Ha-RasV12 and
tested their survival under hypoxia. S51A cells exhibited
progressively higher apoptotic sensitivity to hypoxia com-
pared to WT-MEFS (Figure 5B). Furthermore, exposure of
WT-MEFs to 24 and 48 h of hypoxia resulted in 16 and 60%
decreases in clonogenic survival, respectively, whereas S51A-
transformed MEFs were significantly more sensitive, exhibit-
ing 60 and 100% decreases in survival, respectively (Figure
5C and D). The increased levels of cell death in the S51A cells
were accompanied by higher levels of cleaved caspase-3 and
PARP at 16 and 24 h of hypoxia compared to WT-MEFs
(Figure 5E). Thus, the higher sensitivity of S51A cells to
hypoxia compared to WT cells is similar to that of the
PERK/ cells and parallels the sensitivity of S51A cells to
other ER stressors like thapsigargin (Harding et al, 2000b).
Phosphorylation of eIF2a affects tumor growth and ISR
signaling in vivo
As was the case with PERK/ and PERKþ /þ transformed
MEFs, in vitro growth rates of SV40/Ha-RasV12-transformed
WTand S51A MEFs were very similar (Figure S2C). However,
when injected into nude mice, the S51A tumors grew slower
during the first 14 days following inoculation, and, between
days 14 and 21, the majority of S51A tumors developed areas
of apparent necrosis (Figure 6A) and the animals had to be
euthanized. At that time, the average weight of S51Á tumors
was approximately half of that of WT tumors (179726 versus
318777 mg, respectively; Po0.05%) (Figure 6B). Similar to
the PERK/ tumors, the S51A tumors exhibited extensive
colocalization of apoptotic and hypoxic areas (Figure S3A,
a–f and m, n), whereas hypoxic areas of WT tumors were
largely devoid of apoptotic cells and apoptosis was confined
to necrotic areas (Figure S3A, g–l and o, p). Quantitative
image analysis showed that in WT tumors only 17% of
apoptotic cells were in hypoxic regions, compared to 80%
in tumors from the S51A cells (Figure S3B). Furthermore, the
difference in tumor weight was not due to differences in the
angiogenic response to hypoxia, since secretion of VEGF
was not statistically different between the two cell types
(Figure 6C). To determine whether the induction of the ISR
in vivo is eIF2a-dependent, we analyzed the induction of
ATF4 in the two tumor types. WT tumors displayed areas of
ATF4 expression that colocalized with hypoxia, whereas the
S51A tumors were devoid of any significant staining for ATF4
(Figure 6D). We failed to detect any significant expression of
ATF4 in 6/6 S51A sections obtained from three different
mouse tumors. These results indicate that eIF2a phosphor-
ylation is required for hypoxic induction of ATF4 in vivo.
Thus, the phenotype of S51A tumors paralleled that of the
Figure 5 MEFs with nonphosphorylatable eIF2a mutant are more
sensitive to extreme hypoxia than WT MEFs. (A) WT and S51A
MEFs were exposed to p0.02% O2 or treated with 1mM thapsigar-
gin before immunoblotting with anti-phospho-eIF2a or anti-total-
eIF2a antibodies. (B) WT and S51A MEFs transformed with SV40/
Ha-RasV12 were exposed to extreme hypoxia (p0.02% O2) and
then photographed using phase-contrast microscopy. (C) Reduced
clonogenic survival of S51A MEFs after hypoxia compared to WT
MEFs. (D) Reduced survival of S51A MEFs after hypoxia compared
to WT MEFs, as measured by clonogenic survival assay. Cells were
treated as in (C). Experiments were performed in triplicate and error
bars represent standard errors. (E) WTand S51A MEFS transformed
with SV40/Ha-RasV12 were exposed to hypoxia or treated with
500 nM thapsigargin before immunoblotting for cleaved caspase-3,
PARP or b-actin.
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PERK/ tumors, indicating that the PERK-eIF2a component
of the ISR is required for in vivo resistance to hypoxic stress
and tumor growth.
Expression of a dominant-negative PERK (dn-PERK)
allele in human tumor cells reduces hypoxia tolerance
and inhibits tumor growth
The results presented so far were obtained using minimally
transformed MEFs, a useful and informative isogenic system,
but one that may not be representative of human tumor cells
of epithelial origin. To examine the role of the PERK-eIF2a
pathway in vitro and in vivo, we used a dn-PERK construct to
block the activity of endogenous PERK in an established
human cancer cell line. This dn-allele, PERKDC, lacks the
C-terminal kinase domain, has a myc-tag epitope and was
shown to inhibit the ability of endogenous PERK to phos-
phorylate eIF2a following various stresses, including hypo-
xia (Brewer and Diehl, 2000; Koumenis et al, 2002). HT29
colorectal carcinoma cells stably expressing the dn-PERK
construct (HT29.PERKDC), or the empty vector (HT29.Puro)
were exposed to normoxia or 6 h of extreme hypoxia.
HT29.PERKDC cells failed to increase eIF2a phosphorylation
after 6 h of hypoxia, confirming that this construct exerts a
dominant-negative function by inhibiting endogenous PERK
activity (Figure 7A). We next tested the apoptotic sensitivity
of these cells to hypoxia and thapsigargin. After 32 h of
extreme hypoxia, substantially higher levels of cleaved
PARP were observed in the HT29.PERKDC cells compared
to the HT29.Puro cells (Figure 7B, top). The HT29.PERKDC
cells also displayed morphology consistent with swollen
ER, indicative of ER stress (Figure 7B, bottom). The in vitro
growth of the control and PERKDC cell lines was not sig-
nificantly different over a period of 12 days in culture (data
not shown) and HIF-1a was induced to comparable levels in
both cell lines (Figure 7C), confirming that HIF-1 regulation is
not dependent on PERK status. To test the role of PERK in
HT29 tumor growth, cells were injected into the flanks of
nude mice and tumor volume was followed for up to 25 days.
Tumors obtained from HT29.PERKDC cells grew significantly
smaller compared to those obtained from the HT29.Puro cells
(Figure 7D and E), providing additional evidence that inhibi-
tion of PERK activity hinders tumor growth in vivo.
Immunoblot analysis from homogenized tumors showed
that expression of the dn-PERKDC allele was retained for
the duration of tumor growth and correlated with inhibition
of eIF2a phosphorylation in the HT29.PERKDC tumors
(Figure 7F). Also, similar to the PERK/ MEF tumors, the
HT29.PERKDC tumors displayed extensive colocalization of
Figure 6 Inhibition of eIF2a phosphorylation affects the rate of tumor growth in vivo. (A) Nu/Nu mice were injected on each side with
1106 cells/site, with either WT.Ha-RasV12 MEFs (left panel) or S51A.Ha-RasV12 MEFs (right panel). Necrotic areas on the skin and opaque
morphology are evident in the S51A.Ha-RasV12 tumors. (B) Tumor growth after 3 weeks. At the end of the experiment, tumors were excised
and weighed (mean7s.e., N¼ 7, *Po0.05, one-tailed Student’s t-test). (C) VEGF levels following hypoxia in WT and S51A MEFs. Ras-
transformed MEFs were treated as in Figure 5A and secreted VEGF levels in the media were analyzed at the times indicated. Experiments were
performed in triplicate and error bars represent s.e. values. (D) ATF4 upregulation in hypoxic areas is dependent on eIF2a phosphorylation.
Tumor xenografts from Ha-RasV12-transformed WT and S51A cells were stained for ATF4 expression. Staining for ATF4 was observed only
in WT tumors and localized within hypoxic regions. No significant staining was seen in 6/6 sections from three different S51A tumors.
Bar¼ 15 mm.
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apoptosis with areas of hypoxia. In contrast, the HT29.Puro
tumors had larger hypoxic areas that were largely devoid of
apoptotic cells (Figure 7G). Collectively, these results provide
further evidence that inhibition of PERK activity com-
promises hypoxia tolerance of tumor cells in vitro and
in vivo.
Cells lacking ATF4 are sensitive to hypoxic stress and
expression of the ISR proteins ATF4 and CHOP is
upregulated in hypoxic areas of primary human tumors
Since both PERK/ and S51A MEFs were more sensitive
to hypoxia compared to the corresponding WT-MEFs, we
wished to determine whether lack of the downstream target
ATF4 would result in a similar phenotype. Extreme hypoxia
resulted in significant levels of apoptosis in the ATF4/
MEFs but not in ATF4þ /þ MEFs, which was evident both
morphologically (Figure 8A) and by cleaved caspase-3 and
cleaved PARP analysis (Figure 8B). The sensitivity of ATF4/
cells to hypoxia also occurred at more moderate hypoxic
levels. Exposure of the MEFs to 1% O2 resulted in a 55%
decrease in survival in ATF4/ cells compared to 25% in
ATF4þ /þ cells as assayed by MTT assay, whereas the sensi-
tivity of the two cell types to a different stress, ionizing
radiation, was the same (Figure 8C).
Figure 7 Expression of a dn-PERK allele in human tumor cells decreases hypoxia tolerance and inhibits tumor growth. (A) Immunoblot of
myc-tagged PERKDC, eIF2a phosphorylation and b-actin (loading control). Exposure of HT29.Puro cells to extreme hypoxia induces an
increase in eIF2a phosphorylation, which is blocked in HT29.PERKDC cells. (B) Immunoblot of uncleaved and cleaved PARP in HT29.Puro and
HT29.PERKDC cells following hypoxia or 12 h treatment with 500 nM thapsigargin (top). b-Actin was used as a loading control. Apoptotic
morphology following extreme hypoxia for 48 h at  40 magnification (bottom). Arrowheads indicate cells with membrane blebbing and
arrows indicate cells exhibiting vacuoles, a sign of ER stress. (C) PERK status does not affect induction of HIF-1a levels. HT29.Puro
and HT29.PERKDC cells were treated with extreme hypoxia or DFO. HIF-1a levels were determined by immunoblotting using nuclear extracts.
(D) Tumor xenografts from HT29.Puro cells (left mouse) grow larger compared to tumors from HT29.PERKDC cells (right mouse). (E) Growth
measurements of HT29.Puro xenografts (blue line and squares) and HT29.PERKDC xenografts (green line and triangles). Growth from six
tumors was monitored over a period of 25 days following injection (mean7s.e.) (*Po0.05). (F) Immunoblot analysis of PERKDC expression,
eIF2a phosphorylation status or total eIF2a levels from excised and homogenized tumors shown in (D, E). (G) Sections from HT29.Puro and
HT29.PERKDC xenografts were stained for regions of hypoxia using a Cy-3-labeled anti-EF-5 antibody and apoptosis using an anti-cleaved
caspase-3, FITC-labeled antibody. The merged images are shown on the right.
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To investigate whether the induction of the ISR also occurs
in primary human tumors, we analyzed ATF4 and CHOP
levels in human cervical tumor sections obtained from
patients that had been injected with the hypoxia-sensitive
dye pimonidazole (Varia et al, 1998). Immunohistochemical
staining showed significant intra- and intertumoral variations
of ATF4 and CHOP expression. However, expression of both
proteins colocalized with either hypoxic areas or areas ad-
jacent to hypoxic regions. ATF4 expression showed stronger
association with highly hypoxic areas (pimonidazole-positive
staining, Figure 8D), whereas CHOP expression was
associated with highly hypoxic and surrounding areas
(Figure 8D). Similar results were obtained in four different
sections obtained from two distinct cervical tumors (Figure
S4A). We also examined ATF4 expression in several normal
and malignant tissues obtained from patients with brain,
breast, cervical and skin cancers. The expression of ATF4
was significantly higher in all malignant tissues compared to
the corresponding normal tissues (Figures 8E and F and
Figure S4B). The results with ATF4 are in agreement with a
previously reported study in which ATF4 expression was
found to be higher in breast tumors than in normal breast
tissue, and to be present near necrotic areas (Ameri et al,
2004).
Discussion
We have presented evidence that the ISR arm of the UPR is
activated by hypoxic/anoxic stress in vitro and in hypoxic/
anoxic areas of solid tumors, and that failure of tumor cells to
mount an effective ISR in response to low oxygen results in
increased apoptosis, reduced overall cell survival and inhibi-
tion of tumor growth. Recently, a study by Chen et al showed
that XBP1, the target of IRE1, is essential for cell survival
under hypoxic conditions and that XBP1 is required for tumor
growth (Romero-Ramirez et al, 2004). Together, these studies
suggest that the full UPR is activated under hypoxia/anoxia
and contributes to cellular adaptation to this stress.
The induction of gene expression under conditions of
global translational repression is reminiscent of other stress
responses (e.g., heat-shock response), during which select
groups of genes are upregulated in a background of repressed
gene expression to help in the recovery from the stress. Thus,
it is noteworthy that several genes with important roles in the
Figure 8 ATF4 contributes to hypoxia tolerance, and ATF4 and CHOP are upregulated in hypoxic areas of primary human tumors. (A) Cells
were exposed to extreme hypoxia for 24 h and photographed for apoptotic morphology at  100 magnification. (B) Immunoblot of cleaved
caspase-3 (top) or uncleaved and cleaved PARP (bottom) following hypoxia. (C) MTT assay of ATF4þ /þ and ATF4/ MEFs following
exposure to moderate hypoxia (1% O2) or treatment with a 4 Gy dose of IR. Experiments were performed in triplicate and results are
normalized to control levels. Error bars represent s.e. values (*Po0.05). No significant difference in survival was observed between untreated
ATF4þ /þ and ATF4/ MEFs. (D) Immunofluorescence for ATF4 and hypoxia (af), or CHOP and hypoxia (gl) in primary human cervical
tumors. Sections were stained with anti-ATF4 (a, d) or anti-CHOP (g, j) polyclonal antibodies followed by a FITC-conjugated secondary
antibody, and with a Cy-3-labeled anti-Pimonidazole antibody (b, e, h, k). Panels c, f, i and l are combined images of (aþb), (dþ e), (gþh),
(jþ k), respectively. Bar¼ 15mm (ac, gi) and 30mm (df, ji). (E) Immunoblot of ATF4 in lysates from human GBMs and normal human
brain tissue. (F) Analysis of ATF4 levels (normalized to levels of b-actin) in normal and malignant tissues obtained from human patients. Error
bars represent s.e. values. Brain, N¼ 6 normal and 6 glioblastoma; breast, N¼ 3 normal and 3 adenocarcinoma; cervix, N¼ 4 normal and 6
carcinoma; skin, N¼ 2 normal and 2 melanoma.
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hypoxic response, including VEGF and HIF-1a, harbor un-
usually long 50 UTRs with extensive secondary structures that
presumably enable them to be efficiently translated under
hypoxic conditions (Akiri et al, 1998; Lang et al, 2002).
Conversely, our screen for genes whose mRNAs are effi-
ciently translated under hypoxic conditions revealed that
several mRNAs of UPR genes, including BiP, CHOP and
ORP150, are among the most efficiently translated mRNAs
(Figure S1). It is tempting to speculate that the hypoxic/
anoxic response and the UPR may share common post-
translational regulation mechanisms.
The complex picture of tumor hypoxia, composed of
significant intra- and intertumoral variations in oxygen levels
that can change dynamically in time, prompted the investiga-
tion of UPR gene expression in hypoxic areas of tumors. We
show that at least two ISR target genes, ATF4 and CHOP, are
highly expressed in hypoxic areas of tumors. Previously,
we demonstrated that induction of eIF2a phosphorylation
(a requirement for significant ATF4 and CHOP accumulation
as shown in Figure S2) can occur at more moderate hypoxic
levels—as high as 1% O2—albeit with slower kinetics
(Koumenis et al, 2002), suggesting that the ISR can be elicited
over a wide range of hypoxic conditions.
What is the physiological role for these proteins in hypoxia
tolerance? ATF4 activates the induction of downstream UPR
genes, but has also been implicated in antioxidant cellular
defense processes (Fawcett et al, 1999; Harding et al, 2003; Lu
et al, 2004). Recent mechanistic studies on HIF-1a induction
appear to support a model of increased oxidative stress in the
cytosol due to release of reactive oxygen species from the
mitochondria (Guzy et al, 2005; Mansfield et al, 2005).
Furthermore, reoxygenation following hypoxia produces oxi-
dative stress severe enough to activate DNA damage response
pathways (Hammond et al, 2003). We hypothesize that
induction of ATF4 by hypoxia serves to upregulate anti-
oxidant-related genes to ameliorate oxidative stress. CHOP,
itself a target of ATF4, is a transcription factor with proapop-
totic properties (Zinszner et al, 1998; McCullough et al,
2001). While CHOP may promote apoptosis under pro-
longed/severe hypoxia, it is evident—as is also the case for
induction of CHOP by pharmacological agents (Harding et al,
2000a)—that the consequences of PERK ablation are signifi-
cantly more severe in terms of apoptosis than an reduced
CHOP expression. Thus, the significance of CHOP induction
by hypoxia at present remains unclear and will have to be
elucidated by using cells with abrogated CHOP expression.
Cells with a compromised ISR pathway show significant
sensitivity to ER stress due to the deleterious effects of
accumulated misfolded proteins in the ER (Harding et al,
2000b; Scheuner et al, 2001). Our results showing PERK-
dependent activation of caspase-12 provide further evidence
of ER stress under hypoxic stress. However, caspase-12/
MEFs display equal sensitivity to prolonged hypoxia com-
pared to their WT-MEFs (data not shown), suggesting that
caspase-12 is not required for hypoxia-induced cell death.
Recently, the BH3-only proapoptotic proteins Bax and Bak
have been localized in the ER membrane and shown to
mediate stress-induced release of ER Ca2þ (Scorrano et al,
2003; Zong et al, 2003), raising the possibility that they could
play a critical role in hypoxia-induced, ER-dependent apoptosis.
An interesting question not addressed by these studies is
the nature of the signal for induction of the UPR by hypoxia/
anoxia. Activation of PERK, IRE1 and ATF6 by ER stress is
negatively regulated by BiP. Under physiological conditions,
BiP binds to the ER-lumenal portion of the proteins and keeps
them in an inactive state (Bertolotti et al, 2000; Shen et al,
2002), and this binding is perturbed during ER stress. One
can envision a scenario in which low oxygen perturbs the
pro-oxidant environment of the ER lumen causing misfolding
of labile proteins, thereby triggering BiP-dependent PERK
activation. This model is supported by the findings that (a)
in yeast, molecular oxygen is the final electron acceptor in
protein disulfide isomerase-dependent protein folding, (b)
BiP expression is upregulated by hypoxia (Gazit et al, 1999)
and (c) downregulation of BiP by antisense cDNA decreases
the survival of tumor cells (Koong et al, 1994). Further
validation of this model will require careful examination of
the interactions between BiP and the initiators of the UPR
under normoxic and hypoxic conditions. Based on the find-
ings presented here, we propose that, in addition to HIF-1-
dependent processes, the induction of the UPR by hypoxia
represents an encompassing and critical aspect of hypoxia
resistance and tumor development. Since stringent hypoxic
conditions do not normally exist outside a tumor micro-
environment, targeting UPR processes could provide an
alternative or complementary approach for therapeutic
exploitation of tumor hypoxia.
Materials and methods
Cell culture and generation of the stable cell lines
PERKþ /þ , PERK/, S51A, ATF4/ and WT MEFs, and HeLa cells
were cultured in DMEM. HT29 colorectal carcinoma cells (ATCC)
were cultured in McCoy’s 5A medium. All media were supplemen-
ted with penicillin, streptomycin, 10% fetal calf serum and
L-glutamine. S51A mutant and ATF4/ MEFs and HT.29PERKDC
cells were also supplemented with 20% FBS, 1 MEM non-
essential amino-acid mix and 55mM 2-mercaptoethanol. Cell trans-
formation and establishment of HT29.PERKDC cells are described in
Supplementary data.
Hypoxia treatments
Cells were placed in either a Bactron 1 Anaerobic Chamber
(Sheldon Manufacturing) or an InVivo2 400 Hypoxia Workstation
(Biotrace, Inc.). for the time(s) indicated. The oxygen concentration
in the anaerobic chamber was maintained at p0.02% and
monitored with a polarographic, membrane-covered oxygen sensor
(Animas Corp.).
Animals
Athymic Nu/Nu mice (Charles River Labs) were subcutaneously
injected with 3106 transformed PERKþ /þ and PERK/ MEFs or
transformed MEF-WT and S51A MEFs or 1.5106 HT29.Puro
or HT.29PERKDC cells in 150ml of PBS. Tumors were monitored
daily until they became cumbersome or necrotic. Tumor volumes
were measured every other day based on the formula
V¼ length2width, where length was always the longest dimen-
sion. For hypoxia visualization, mice were injected with 300ml of
3 mg/ml EF-5 (University of Pennsylvania) i.p. 1 h before euthani-
zation, tumors were immediately excised, frozen and embedded in
OCT freezing medium.
Human tumors
Human cervical squamous cell carcinoma tumors were obtained at
the UNC-CH School of Medicine. Patients were injected with
pimonidazole prior to surgical resection of tumors. Tumors were
flash frozen in liquid nitrogen, embedded in OCT and stored at
801. Human tumor and normal tissues were obtained through the
WFU Comprehensive Cancer Center Tissue Procurement Core Lab.
Collection and processing of human specimens was performed in
accordance to UNC-CH and WFUSM IRB regulations.
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Immunohistochemistry
Frozen tissue was sectioned in 5 mm and fixed to glass slides in 4%
formaldehyde solution for 10 min. For detection of hypoxic areas
using EF-5, sections were further fixed with 100% methanol for
10 min, blocked in 3% BSA in PBS for 30 min and incubated with
a Cy3-conjugated ELK 3–51 (75mg/ml) monoclonal antibody (Uni-
versity of Pennsylvania) that recognizes EF-5 adducts, followed by
incubation with a FITC-conjugated anti-cleaved caspase-3 antibody
(Cell Signaling). Fluorescence was detected using Olympus IX70
Epifluoroscope and photographed at several magnifications. For
detection of hypoxia/ATF4 and hypoxia/CHOP colocalization,
mouse and human cervical tumor sections were fixed in 95, 75
and 50% ethanol, blocked in 3% BSA in PBS and hypoxia adducts
detected with either ELK 3-51 antibody for mouse tumors or Cy3-
conjugated anti-pimonidazole monoclonal antibody (2 mg/ml)
(UNC-CH) for human tumors. Sections were incubated with anti-
CHOP or anti-ATF4 polyclonal antibodies, followed with a FITC-
conjugated secondary antibody.
Immunoblotting
Immunoblotting was performed as previously described (Koumenis
et al, 2002). For primary antibodies used, please see Supplementary
data.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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